Singh, Balraj and Ayad, Sarah and Kaur, Parminder and Kumar, Vinod and Gupta, Sachin and Maroules, Michael (2021) COVID-19-Induced Pancytopenia in a Major Molecular Response CML Patient on Dasatinib: A Case Report and Review of the Literature. European Journal of Case Reports in Internal Medicine, 8 (1). pp. 1-4. ISSN ISSN: 2284-2594
|
Text
2233-Article Text-19580-1-10-20210112.pdf - Published Version Download (859kB) | Preview |
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has caused a global health crisis. COVID-19 can have a multifaceted presentation, and a wide range of complications and outcomes may emerge based on the severity and comorbidities of the infected patient. We report the case of a 42-year-old man with a history of chronic myeloid leukaemia (CML) on dasatinib (in major molecular response) who was diagnosed with COVID-19 and developed pancytopenia. Our case report and review of available publications add to the limited literature available regarding COVID-19 in CML.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Tyrosine kinase inhibitors, COVID-19, SARS-CoV-2, chronic myeloid leukemia, imatinib, dasatinib, nilotinib, cancer |
| Subjects: | 600 Tecnologia - Scienze applicate 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
| Depositing User: | Marina Spanti |
| Date Deposited: | 20 Dec 2021 15:06 |
| Last Modified: | 20 Dec 2021 15:06 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/21167 |
Actions (login required)
 |
View Item |
